BDNF and osteosarcoma: Future work should prioritize a standardized biomarker framework that resolves cell-type, spatial and temporal features of Trk signaling in human osteosarcoma and supports sex-stratified, puberty-aware analyses of neurotrophin, Trk and immune pathways.